Flash Finance

Global Longlife Hospital and Research Ltd543520Corporate

Hospital Latest results: Mar 2026 10 quarters of data
₹14.97
MCap ₹16 Cr
Global Longlife Hospital and Research Ltd — Stock analysis & AI research Global Longlife Hospital and Research Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Mar 2026
₹-0 Cr
Operating Profit · Mar 2026
-14.3% YoY
—
OPM % · Mar 2026
₹-0 Cr
Net Profit · Mar 2026
+61.5% YoY
₹-0.38
EPS · Mar 2026
+61.6% YoY

📝 Global Longlife Hospital and Research Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

Global Longlife Hospital and Research Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).

The company reported a net loss of ₹0 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.38.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹2 crore.

Valuation snapshot

At the current price of ₹14.97, 543520 has a market capitalisation of ₹16 crore.

Within the Hospital industry, it is the 10th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 22.88%, public shareholders 77.11% of Global Longlife Hospital and Research Ltd.

Promoter holding slipped from 35.44% to 22.88% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹16 Cr
Current Price ?
₹15.0
P/E ?
N/A
Industry P/E ?
39.60
P/B ?
0.66
P/S ?
N/A
P/FCF ?
-3.49
Enterprise Value ?
₹16 Cr
EV/EBITDA ?
-15.72
PEG ?
N/A
Earnings Yield ?
-6.4%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
₹-2 Cr
EPS (TTM) ?
₹-1.64
ROCE ?
-3.9%
ROE ?
-7.2%
ROA ?
-7.2%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹-0 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
61.5%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹0 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
22.88%
Change in promoter holding ?
-32.02%
Pledged percentage ?
N/A
Market
Return 3 months ?
53.2%
Return 6 months ?
3.4%

🗓️ Quarterly results (10 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026 YoY % QoQ %
Sales 201312121211000 — —
Operating Profit 71223-3-4-0-1-0 -14.3% —
Other Income 0000006-100 +100.0% —
Interest 0100000000 — —
Depreciation 1111110000 — —
Profit Before Tax 6-0122-41-1-1-0 +60.8% —
Net Profit 6-0111-31-1-1-0 +61.5% —
EPS 8.81-0.140.721.020.98-3.071.18-0.99-1.26-0.38 +61.6% —
OPM % 33.9% 9.8% 15.0% 19.3% 22.0% -255.9% -656.9% — — — — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 10.5010.5010.5010.50 +0.0%
Reserves 53.7915.4316.2913.25 -18.7%
Borrowings 9.2912.740.000.00 —
Other Liabilities 2.363.070.060.01 -83.3%
Total Liabilities 75.9441.7426.8523.76 -11.5%
Fixed Assets 16.5217.270.000.00 —
CWIP 1.030.000.000.00 —
Investments 0.100.030.030.00 -100.0%
Other Assets 58.2924.4426.8223.76 -11.4%
Total Assets 75.9441.7426.8523.76 -11.5%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -40.42-5.0712.32-4.51 -136.6%
Cash from Investing Activity -1.90-0.8221.800.04 -99.8%
Cash from Financing Activity 45.702.67-13.010.00 +100.0%
Net Cash Flow 3.38-3.2221.11-4.47 -121.2%
Free Cash Flow -42.42-6.1033.42-4.51 -113.5%
CFO/OP -960%2,259%-304%401% +231.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 151.4352.88376.77— —
Inventory Days 69.12131.640.00— —
Days Payable 110.43765.90—— —
Cash Conversion Cycle 110.13-581.38376.77— —
Working Capital Days 344.86-238.361,283.39— —
ROCE % 6.35%-2.51%-13.69%-3.92% +71.4%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 54.90%55.10%35.44%22.88% -35.4%
Public 45.10%44.91%64.56%77.11% +19.4%
No. of Shareholders 9179159851,149 +16.6%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 PARKHOSPS Park Medi ₹280.90 12,133 42.4 1,756 298 26.5% 16.9% — — 19.3% 34.8%
2 526783 Dr Agarwals ₹5,253.00 2,465 33.3 497 75 30.4% 15.2% 18.6% 27.8% 22.2% 37.5%
3 524520 KMC Speciality ₹81.32 2,373 23.8 331 57 30.4% 17.1% 32.5% 108.7% 37.0% 107.2%
4 GKSL Gujarat Kidney ₹172.33 1,359 — — — — — — — — —
5 543346 Aashka Hospitals ₹117.80 195 83.0 23 3 22.8% 14.5% — — 22.3% 55.2%
6 531658 Abate As ₹28.64 120 266.9 — 2 — — — 158.6% — 10.1%
7 523696 Fortis Malar ₹65.66 79 n/m 0 0 -5165.0% 427.8% — 932.5% -95.5% -96.3%
8 544013 KK Shah ₹49.79 30 — 9 -1 8.2% -6.6% — — -7.2% 57.1%
9 539378 Soni Medicare ₹26.49 30 — 23 -4 -8.1% -15.5% -15.9% -1405.6% -39.2% -313.3%
10 543520 Global Longlife ₹30.99 16 — — -2 — — — — — 61.5%
❓ Frequently asked questions
What was Global Longlife Hospital and Research Ltd's revenue in Q4 FY26?
Global Longlife Hospital and Research Ltd reported revenue of ₹0 crore for the quarter ended March 2026 (Q4 FY26).
What was Global Longlife Hospital and Research Ltd's net profit in Q4 FY26?
The company reported a net loss of ₹0 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.38.
What is 543520's market capitalisation and P/E ratio?
At the current price of ₹14.97, 543520 has a market capitalisation of ₹16 crore.
Who owns Global Longlife Hospital and Research Ltd? (shareholding pattern)
As of Mar 2026, promoters held 22.88%, public shareholders 77.11% of Global Longlife Hospital and Research Ltd.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI